EFPIA - NEWSLETTER

EFPIA Newsletter 18 November 2021

Antimicrobial resistance: Let's find the solutions

To fight AMR, bold action is required to build a pipeline for future antimicrobials and give companies confidence to start reinvesting in antimicrobials development.

News

17 November 2021 EFPIA and Vaccines Europe position on the European Health Emergency preparedness and Response...

While during the pandemic the EU reacted to issues as they arose, the creation of HERA is a first step to putting Europe...

15 November 2021 Financing environment of biopharmaceutical SMEs in Europe

Take 10 minutes to fill in our survey

12 November 2021 EFPIA Statement on the 11 November Foreign Affairs Council Meeting

The global biopharmaceutical industry supports a strong international trading system rooted in the WTO core principles...

Blogs

17 November 2021 WTO Members Should Use Their Upcoming Ministerial To Improve Our Ability To Respond To A Health...

It’s become somewhat of a cliché to write that a global crisis requires a global answer. On health, we are convinced...

5 Things to know about the COVID-19 vaccines

The situation around the COVID-19 pandemic is evolving constantly, with new issues coming into focus as we move through the pandemic. The wealth of information can easily become overwhelming, so we’ve summarised 5 key things you need to know about the COVID-19 vaccines. Discover more here.

#WeWontRest #TeamVaccines

1. They’re effective

Hospitalisations and deaths decrease.

2. They meet rigorous safety standards

The COVID-19 vaccine clinical trials are among the largest ever conducted.

Events

23 NOV 2021

Screening for type 1 diabetes: why is it needed? Virtual event

Webinar Hosted By JDRF, INNODIA, and EUDF

Learn more →

29 NOV 2021

Vaccines Tomorrow: The Future of Immunisation Virtual event

#10YearsOfFacts

Learn more →

29 NOV 2021

2021 Clinical Trial Disclosure & Data Transparency Conference Virtual event

Evolving Requirements and New Challenges

Learn more →

09 DEC 2021

Bend but don’t break: Future-proofing the pharmaceutical supply chain Virtual Event

Our guest speakers exchanged on how we can ensure supply chain optimisation and resilience.

Learn more →

We published

The Impact of Pharmaceutical IP Provisions in EU Free Trade Agreements 12 November 2021 (News & Events)

This report examines the impact of past EU FTAs on drug spending, timing of countries’ access to new medicines after...

What we are reading

Pfizer strikes a deal with the Medicines Patent Pool for generic versions of its Covid-19 pill... 16 November 2021 (STAT+)

Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized... 24 October 2021 (ASCPT)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶